Stay updated on Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial
Sign up to get notified when there's something new on the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page.

Latest updates to the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe site footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check22 days agoChange DetectedA banner announces NIH’s website transition and says federal agencies are shifting from the term “Artificial Intelligence” to “Super Intelligence” during the transition.SummaryDifference0.8%

- Check29 days agoChange DetectedThe footer now identifies the site software as revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check36 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site release as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check57 days agoChange DetectedThe navigation item was changed from 'Find Contact Information' to 'Find contact information'. The history log reflects a minor version update with Revision: v3.7.0 added and Revision: v3.6.6 removed.SummaryDifference0.2%

- Check78 days agoChange DetectedThe study record history now shows a new revision entry, v3.6.6, superseding v3.6.5. It represents an update to the record metadata rather than substantive changes to the trial details.SummaryDifference0.1%

Stay in the know with updates to Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page.